GlassScriptPhysician profile
April Lov Jasper
NPI 1417957937
$553,440.29
in general payments reported to CMS, 2019-2025
30 companies · $150K in 2025
The $150K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117K · 2020: $31K · 2021: $96K · 2022: $52K · 2023: $21K · 2024: $87K · 2025: $150K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $166K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $62K · Travel and Lodging: $17K · Food and Beverage: $7,853 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,125 · Honoraria: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $166,412.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $62,268.00 |
| Travel and Lodging | $16,885.74 |
| Food and Beverage | $7,853.23 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,125.00 |
| Honoraria | $350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $337,280.60 | 2019-2025 | Total30, Dailies Total1, Precision7 |
| Reichert, INC. | $87,880.80 | 2019-2025 | Vrx and Dry Eye Products, Tono-Vera Tonometer US Starter Kit Human Rechargable, Viewer License |
| Carl Zeiss Meditec, INC. | $26,219.47 | 2019-2024 | Forum, Humphrey Hfa, Iolmaster 700 |
| Alcon Research LLC | $19,542.57 | 2022-2024 | |
| Allergan, INC. | $14,339.91 | 2019-2022 | |
| Lombart Brothers, INC. | $13,500.00 | 2019 | |
| Sun Pharmaceutical Industries INC. | $11,912.74 | 2019-2025 | Cequa, Xelpros, Bromsite |
| Bausch & Lomb Americas INC. | $8,609.16 | 2022-2025 | Miebo, Xiidra, Blink Nutritears |
| Sight Sciences, INC. | $8,384.16 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $4,822.53 | 2019-2022 | |
| Harrow Eye, LLC | $4,389.82 | 2024-2025 | Vevye |
| Carl Zeiss Meditec USA, INC. | $4,164.90 | 2022-2024 | Cirrus Hd-Oct, Humphrey Field Analyzer (Hfa3), Iolmaster 700 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $4,134.20 | 2019-2021 | |
| Abbvie INC. | $3,429.33 | 2022-2024 | |
| Oyster Point Pharma, INC. | $1,932.25 | 2022-2024 | Tyrvaya |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tearlab Corp | $1,379.54 | 2022-2023 | Tearlab Osmolarity System |
| Coopervision INC. | $403.58 | 2020-2025 | Myday Contact Lens, Misight Contact Lens, Paragon Crt |
| Dompe US, INC. | $261.80 | 2020-2024 | Oxervate |
| Glaukos Corporation | $147.12 | 2021-2024 | Radius |
| Visionary Optics LLC | $135.46 | 2024 | |
| Kala Pharmaceuticals, INC. | $124.48 | 2021 | |
| Abb Con-Cise Optical Group LLC | $110.32 | 2019-2020 | |
| Haag-Streit USA, INC. | $81.95 | 2022-2024 | |
| Shire North American Group INC | $78.71 | 2019 | |
| Visioneering Technologies, INC. | $38.81 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $32.82 | 2019 | |
| Maculogix, INC. | $30.78 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $26.97 | 2024 | |
| Eyevance Pharmaceuticals LLC | $26.11 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Jasper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.